Pancreatic tumours escape from translational control through 4E-BP1 loss
Yvan Martineau(Centre National de la Recherche Scientifique), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Sally El Khawand(Centre de Recherche en Cancérologie de Toulouse), Corinne Bousquet(Centre National de la Recherche Scientifique), David C. Muller(UNSW Sydney), Rodica Anesia(Inserm), Jerry Pelletier(McGill University), R Azar(Inserm), Charline Lasfargues(Inserm)
Cited by 67
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
|PLoS ONE|2009|291
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284